Mark Woolf

Mark is a seasoned professional with a wealth of experience in global depot storage and distribution, as well as a deep understanding of regulatory requirements in various clinical trial destination countries and regions. His unique perspective and local knowledge come from several years of residency in Europe, the Middle East, Africa, and APAC countries.

With 22 years of logistics experience and another 18 years in clinical trial supply chain logistics, QA, and vendor management roles, Mark has a track record of delivering results in complex and dynamic environments. He has also gained extensive freight forwarding and regulatory experience within free trade zones in Turkey and Africa.

Mark’s career includes stints at several prominent companies in the pharma and logistics industries. He worked at Zuellig Pharma Asia Pacific in a QA role, Almac Clinical Services as a vendor manager, Maersk Shipping in West African nations and port terminal management roles, Catalent Pharma Solutions as a supplier and vendor manager, and as an independent contractor. Most recently, he has been serving as the Director of Technical Operations at Tanner Pharma and currently holds the position of Chief Business Development Officer at Oximio – (SMO Group).

Mark’s expertise, extensive experience, and excellent business acumen have made him a valuable asset in the field of clinical trial supply chain logistics, and he continues to play an important role in advancing the industry.

.